X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4497) 4497
Newsletter (352) 352
Newspaper Article (51) 51
Magazine Article (30) 30
Book Chapter (10) 10
Dissertation (6) 6
Publication (2) 2
Book / eBook (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
simvastatin (3332) 3332
science & technology (3261) 3261
life sciences & biomedicine (3077) 3077
humans (2560) 2560
male (2233) 2233
female (1633) 1633
simvastatin - administration & dosage (1541) 1541
animals (1305) 1305
middle aged (1271) 1271
simvastatin - therapeutic use (1126) 1126
simvastatin - pharmacology (1023) 1023
statins (974) 974
pharmacology & pharmacy (939) 939
aged (925) 925
antilipemic agents (818) 818
adult (779) 779
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (756) 756
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (689) 689
research (678) 678
cholesterol (666) 666
rats (620) 620
cardiovascular system & cardiology (610) 610
treatment outcome (583) 583
dosage and administration (578) 578
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (564) 564
hypercholesterolemia - drug therapy (535) 535
anticholesteremic agents - administration & dosage (517) 517
cardiac & cardiovascular systems (511) 511
lipids (509) 509
drug therapy, combination (506) 506
cholesterol, ldl - blood (485) 485
abridged index medicus (476) 476
risk factors (452) 452
dose-response relationship, drug (451) 451
drug therapy (448) 448
simvastatin - adverse effects (448) 448
anticholesteremic agents - therapeutic use (443) 443
analysis (428) 428
mice (393) 393
hypercholesterolemia (370) 370
cholesterol - blood (368) 368
care and treatment (366) 366
general & internal medicine (339) 339
atorvastatin calcium (326) 326
double-blind method (324) 324
atorvastatin (322) 322
time factors (322) 322
ezetimibe (318) 318
disease models, animal (301) 301
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (301) 301
drugs (300) 300
medicine, general & internal (300) 300
cardiovascular diseases (299) 299
drug interactions (298) 298
health aspects (292) 292
rats, sprague-dawley (284) 284
statin (260) 260
triglycerides - blood (257) 257
lipids - blood (252) 252
low density lipoproteins (249) 249
peripheral vascular disease (246) 246
hypercholesterolemia - blood (245) 245
cardiovascular disease (240) 240
heptanoic acids - administration & dosage (232) 232
inflammation (232) 232
pyrroles - administration & dosage (231) 231
lovastatin - analogs & derivatives (230) 230
atherosclerosis (227) 227
rats, wistar (227) 227
medicine & public health (224) 224
complications and side effects (222) 222
hypolipidemic agents - administration & dosage (222) 222
nutritional and metabolic diseases (222) 222
simvastatin - pharmacokinetics (219) 219
aged, 80 and over (213) 213
medicine (212) 212
anticholesteremic agents - pharmacology (210) 210
hypolipidemic agents - therapeutic use (209) 209
cholesterol, hdl - blood (206) 206
medicine, research & experimental (205) 205
research & experimental medicine (205) 205
studies (203) 203
anticholesteremic agents - adverse effects (198) 198
heptanoic acids - therapeutic use (198) 198
pyrroles - therapeutic use (196) 196
biochemistry & molecular biology (195) 195
rodents (195) 195
azetidines - administration & dosage (193) 193
diabetes (193) 193
hyperlipidemias - drug therapy (193) 193
physiological aspects (193) 193
cardiovascular (192) 192
neurosciences & neurology (192) 192
medical research (191) 191
apoptosis (190) 190
clinical trials (188) 188
research article (182) 182
drug combinations (181) 181
drug administration schedule (178) 178
cell biology (177) 177
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4785) 4785
German (47) 47
Russian (37) 37
Japanese (33) 33
Chinese (30) 30
Portuguese (29) 29
Swedish (19) 19
Spanish (14) 14
Italian (13) 13
French (11) 11
Norwegian (9) 9
Danish (8) 8
Hungarian (7) 7
Polish (6) 6
Czech (5) 5
Turkish (3) 3
Dutch (2) 2
Korean (2) 2
Croatian (1) 1
Finnish (1) 1
Hebrew (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA : the journal of the American Medical Association, ISSN 0098-7484, 05/2014, Volume 311, Issue 18, pp. 1870 - 1882
Journal Article
Journal Article
European journal of clinical pharmacology, ISSN 0031-6970, 08/2012, Volume 69, Issue 3, pp. 477 - 487
.... Co-administration of ticagrelor with each statin was well tolerated. Exposure to ticagrelor and its active metabolite, AR-C124910XX, was generally unchanged by a single dose of either statin, except for a minor increase in ticagrelor... 
Co-administration | AZD6140 | Biomedicine | Simvastatin | Atorvastatin | Pharmacology/Toxicology | Ticagrelor | Pharmacokinetics | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Adenosine - pharmacokinetics | Purinergic P2Y Receptor Antagonists - administration & dosage | Pyrroles - pharmacokinetics | Simvastatin - adverse effects | Area Under Curve | Heptanoic Acids - pharmacokinetics | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - blood | Half-Life | Male | Metabolic Clearance Rate | Heptanoic Acids - adverse effects | Simvastatin - blood | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Interactions | Pyrroles - administration & dosage | Adenosine - adverse effects | Biotransformation | Platelet Aggregation Inhibitors - administration & dosage | Heptanoic Acids - administration & dosage | Pyrroles - adverse effects | Adult | Female | Platelet Aggregation Inhibitors - pharmacokinetics | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Drug Administration Schedule | Simvastatin - administration & dosage | Purinergic P2Y Receptor Antagonists - pharmacokinetics | Linear Models | Pyrroles - blood | Simvastatin - pharmacokinetics | Adenosine - administration & dosage | Cross-Over Studies | Atorvastatin Calcium | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Adenosine - analogs & derivatives | Least-Squares Analysis | Heptanoic Acids - blood | Dosage and administration | Metabolites | Drug interactions | Antilipemic agents | Drug therapy | Pharmacology | Kinetics | Index Medicus
Journal Article
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2010, Volume 105, Issue 1, pp. 69 - 76
Journal Article
Circulation Cardiovascular quality and outcomes, ISSN 1941-7713, 07/2012, Volume 5, Issue 4, pp. 463 - 471
Background-A daily single capsule (polycap) of 3 blood pressure (BP) lowering drugs (hydrochlorthiazide, 12.5 mg; atenolol, 50 mg; ramipril, 5 mg) at low... 
Cardiovascular disease | Lipids | Blood pressure | Risk factors | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Tablets | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Hypertension - drug therapy | Male | Ramipril - administration & dosage | Polypharmacy | Time Factors | Atenolol - administration & dosage | Platelet Aggregation Inhibitors - adverse effects | Cardiovascular Diseases - etiology | Cardiovascular Diseases - physiopathology | Risk Assessment | Administration, Oral | Simvastatin - administration & dosage | Risk Factors | Biomarkers - blood | Antihypertensive Agents - adverse effects | Hypertension - metabolism | India | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Analysis of Variance | Potassium - urine | Creatinine - blood | Hypercholesterolemia - complications | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Biomarkers - urine | Antihypertensive Agents - administration & dosage | Hypercholesterolemia - drug therapy | Aspirin - administration & dosage | Dose-Response Relationship, Drug | Heart Rate - drug effects | Capsules | Platelet Aggregation Inhibitors - administration & dosage | Cholesterol, LDL - blood | Female | Blood Pressure - drug effects | Dietary Supplements - adverse effects | Cardiovascular Diseases - metabolism | Double-Blind Method | Treatment Outcome | Hydrochlorothiazide - administration & dosage | Hypertension - physiopathology | Potassium - adverse effects | Potassium - administration & dosage | Hypertension - complications | Potassium - blood | Aged | Hypercholesterolemia - metabolism | Drug Combinations | Index Medicus
Journal Article
The American journal of cardiology, ISSN 0002-9149, 07/2003, Volume 92, Issue 2, pp. 152 - 160
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 1/2008, Volume 100, Issue 2, pp. 134 - 139
Journal Article
PloS one, ISSN 1932-6203, 09/2011, Volume 6, Issue 9, pp. e24966 - e24966
In this study, we examined the effect of chronic administration of simvastatin immediately after status epilepticus (SE... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Neurons - pathology | Simvastatin - therapeutic use | Cytokines - metabolism | Enzyme-Linked Immunosorbent Assay | Rats, Wistar | Mossy Fibers, Hippocampal - drug effects | Status Epilepticus - chemically induced | Status Epilepticus - pathology | Rats | Epilepsy, Temporal Lobe - physiopathology | Male | Epilepsy, Temporal Lobe - complications | Animals | Anticholesteremic Agents - therapeutic use | Excitatory Amino Acid Agonists - toxicity | Mossy Fibers, Hippocampal - pathology | Behavior, Animal - drug effects | Kainic Acid - toxicity | Neurons - drug effects | Chronic Disease | Epilepsy, Temporal Lobe - prevention & control | Interleukins | Tumor necrosis factor | Neurons | Simvastatin | Temporal lobe epilepsy | Seizures (Medicine) | Intermediate filament proteins | Status epilepticus | Antilipemic agents | Brain | Interneurons | Traumatic brain injury | Epilepsy | Memory | Interleukin | Staining | Neurosurgery | Neuronal-glial interactions | Convulsions & seizures | Neurodegeneration | Rodents | Tumor necrosis factor-TNF | Statins | Temporal lobe | Cytokines | Glial fibrillary acidic protein | EEG | Tumor necrosis factor-α | IL-1β | Cholesterol | Gliosis | Hospitals | Pyramidal cells | Aberration | Alzheimers disease | Kainic acid | Hippocampus | Apoptosis | Index Medicus
Journal Article